Boston Scientific Corporation (BSX)
$43.31-1.21%Close
SELLRECOVERY · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV14.9%–86.7%
- Market cap
- $64.4B
- Beta
- 0.57
- P/E (TTM)
- 17.46
- IV-%ile
- 48
- IV ATM
- 35.6%
- Short % float
- 2.80%
- Days to cover
- 1.9
- SI change
- -10.9%
- 1W
- +2.65%
- 1M
- -3.86%
- vs SPY 1W
- +2.79%
- vs SPY 1M
- -6.37%
Industry peers
FMP comparable companies · ranked by market cap
- MDTSELLMedtronic Plc$119.1BRECOVERYQ 14$93.01+1.17%
- EWSELLEdwards Lifesciences Corporation$49.1BBEARQ 18$85.27-1.30%
- PENBUYPenumbra, Inc.$12.6BBULLQ 27$320.01-0.30%
- TFXSELLTeleflex Incorporated$5.5BBEARQ 11$124.44-1.00%
- MMSIBUYMerit Medical Systems, Inc.$5.3BBULLQ 13$88.14-1.79%
- LIVNSELLLivaNova PLC$4.2BBEARQ 2$76.37-1.16%
- ATRCSELLAtriCure, Inc.$2.9BBEARQ 20$56.87-0.72%
- CNMDSELLCONMED Corporation$1.4BRECOVERYQ 13$45.55+0.42%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BSX?
- LOPJLB’s latest quantitative signal on Boston Scientific Corporation (BSX) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is BSX in?
- Boston Scientific Corporation (BSX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Boston Scientific Corporation (BSX) do?
- Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these…